日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correlation Between mRNA Expression of Activated Eosinophils and Air Pollutant Exposure in Patients With Asthma

哮喘患者活化嗜酸性粒细胞mRNA表达与空气污染物暴露的相关性

Lin, Ting-Yu; Chang, Po-Jui; Lo, Chun-Yu; Chuang, Hsiao-Chi; Lee, Chung-Shu; Chang, Chih-Hao; Yu, Chih-Teng; Hsieh, Meng-Heng; Liu, Chien-Ying; Kuo, Chih-Hsi Scott; Lin, Shu-Min

A Single-Institute Experience with C-ros Oncogene 1 Translocation in Non-Small Cell Lung Cancers in Taiwan

台湾一家机构对非小细胞肺癌中C-ros癌基因1易位的研究经验

Wang, Hsiang-Sheng; Liu, Chien-Ying; Hsu, Sheng-Chi; Huang, Shih-Chiang; Hung, Tsai-Hsien; Ng, Kwai-Fong; Chen, Tse-Ching

First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer

在一项大型真实世界非小细胞肺癌患者队列研究中,第一代或第二代表皮生长因子受体酪氨酸激酶抑制剂的疗效

Huang, Allen Chung-Cheng; Huang, Chi-Hsien; Ju, Jia-Shiuan; Chiu, Tzu-Hsuan; Tung, Pi-Hung; Wang, Chin-Chou; Liu, Chien-Ying; Chung, Fu-Tsai; Fang, Yueh-Fu; Guo, Yi-Ke; Kuo, Chih-Hsi Scott; Yang, Cheng-Ta

A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed

一项回顾性研究比较了阿来替尼与色瑞替尼在克唑替尼治疗失败的伴有间变性淋巴瘤激酶融合基因的晚期非小细胞肺癌患者中的疗效。

Kuo, Chih-Hsi Scott; Tung, Pi-Hung; Huang, Allen Chung-Cheng; Wang, Chin-Chou; Chang, John Wen-Cheng; Liu, Chien-Ying; Chung, Fu-Tsai; Fang, Yueh-Fu; Guo, Yi-Ke; Yang, Cheng-Ta

Targeted Sequencing of Circulating Cell Free DNA Can Be Used to Monitor Therapeutic Efficacy of Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients

循环游离DNA靶向测序可用于监测酪氨酸激酶抑制剂在非小细胞肺癌患者中的治疗效果

Chiou, Chiuan-Chian; Wang, Chih-Liang; Luo, Ji-Dung; Liu, Chien-Ying; Ko, How-Wen; Yang, Cheng-Ta

Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer

在真实世界中,对接受放化疗的III期不可切除非小细胞肺癌患者进行度伐利尤单抗巩固治疗

Chu, Chia-Hsun; Chiu, Tzu-Hsuan; Wang, Chin-Chou; Chang, Wen-Chen; Huang, Allen Chung-Cheng; Liu, Chien-Ying; Wang, Chih-Liang; Ko, Ho-Wen; Chung, Fu-Tsai; Hsu, Ping-Chih; Guo, Yi-Ke; Kuo, Chih-Hsi S; Yang, Cheng-Ta

Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non-small cell lung cancer: Results of a single-arm prospective cohort study

口服长春瑞滨联合顺铂及同步放疗作为III期非小细胞肺癌诱导治疗:一项单臂前瞻性队列研究的结果

Hsu, Ping-Chih; Chang, John Wen-Chang; Wang, Chun-Chieh; Wu, Chen-Te; Lin, Yu-Ching; Wang, Chih-Liang; Lin, Tin-Yu; Li, Shih-Hong; Wu, Yi-Chen; Kuo, Scott Chih-Hsi; Yang, Cheng-Ta; Liu, Chien-Ying; Chen, Chih-Hung

Front-line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control

对于伴有间变性淋巴瘤激酶融合的非小细胞肺癌亚洲患者,一线治疗方案中色瑞替尼的疗效优于克唑替尼:系统性进展控制的作用

Huang, Shih-Hao; Huang, Allen Chung-Cheng; Wang, Chin-Chou; Chang, Wen-Chen; Liu, Chien-Ying; Pavlidis, Stelios; Ko, Ho-Wen; Chung, Fu-Tsai; Hsu, Ping-Chih; Guo, Yi-Ke; Kuo, Chih-Hsi Scott; Yang, Cheng-Ta

Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer

比较化疗联合免疫检查点抑制剂与单独使用免疫检查点抑制剂治疗晚期和转移性非小细胞肺癌的疗效

Kuo, Chih-Hsi Scott; Wang, Chin-Chou; Huang, Yu-Chen; Pavlidis, Stelios; Liu, Chien-Ying; Ko, How-Wen; Chung, Fu-Tsai; Lin, Tin-Yu; Wang, Chih-Liang; Guo, Yi-Ke; Yang, Cheng-Ta

Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR-mutant and EGFR-wild type nonsquamous non-small cell lung cancer

贝伐珠单抗早期及长期治疗对EGFR突变型和EGFR野生型非鳞状非小细胞肺癌患者总生存期的影响

Huang, Yu-Chen; Shen, Shih-Min; Liu, Chien-Ying; Pavlidis, Stelios; Wang, Chih-Liang; Ko, How-Wen; Chung, Fu-Tsai; Lin, Tin-Yu; Feng, Po-Hao; Lee, Kang-Yun; Guo, Yi-Ke; Yang, Cheng-Ta; Kuo, Chih-Hsi Scott